ARTICLE | Clinical News
BI 695501: Ph III data
January 20, 2017 9:33 PM UTC
Last October, Boehringer reported top-line data from a double-blind, international Phase III trial in 645 patients with moderate to severe active RA who were treated with methotrexate showing that BI ...
BCIQ Company Profiles
BCIQ Target Profiles